...
首页> 外文期刊>Magnesium research: official organ of the International Society for the Development of Research on Magnesium >Effects of chronic administration of calcium-magnesium soft gels on morphine tolerance and dependence in mice.
【24h】

Effects of chronic administration of calcium-magnesium soft gels on morphine tolerance and dependence in mice.

机译:长期施用钙镁软凝胶对小鼠吗啡耐受性和依赖性的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of present study was to assess the effects of chronic administration of calcium-magnesium soft gels on the development of morphine tolerance and dependence in mice. Tolerance was assessed using the tail-pinch test and withdrawal signs of morphine were precipitated by injecting naloxone 2 h after the final morphine injection. CalMag capsules were given in final doses of 50/25, 25/12.5 and 12.5/6.25 mg/kg based on calcium/magnesium ratio. Similar doses of Ca and/or Mg were prepared, separately. CalMag at 50/25, 25/12.5 mg/kg and the mixture of calcium and magnesium (Ca + Mg) at 50/25, 25/12.5, 12.5/6.25 mg/kg and calcium at 50, 25 mg/kg significantly reduced the number of jumps. The number of standings was only reduced after the administration of CalMag at 50/25 mg/kg and Ca + Mg at 25/12.5 mg/kg. The development of morphine tolerance was prevented in all drug-treated groups, except the one which received 6.25 mg/kg Mg. The data suggested that combination of calcium and magnesium at 50/25 and 25/12.5 mg/kg prevented the development of tolerance and dependence. It seems that other ingredients of CalMag capsules do not have an important effect on preventing tolerance and withdrawal signs. Compared to the acute effects, chronic administration of Cal-Mag allowed the effective dose to be reduced. Unlike the acute treatment, chronic administration of calcium alone was effective in reducing morphine tolerance and dependence, and magnesium had no significant effect on withdrawal signs, suggestive of some pharmacological adaptations.
机译:本研究的目的是评估长期施用钙镁软凝胶对小鼠吗啡耐受性和依赖性发展的影响。使用尾捏试验评估耐受性,并在最终吗啡注射后2小时注射纳洛酮沉淀出吗啡的戒断症状。 CalMag胶囊的最终剂量为50 / 25、25 / 12.5和12.5 / 6.25 mg / kg(基于钙/镁比)。分别制备相似剂量的Ca和/或Mg。 50 / 25、25 / 12.5 mg / kg的CalMag和50 / 25、25 / 12.5、12.5 / 6.25 mg / kg的钙镁混合物(Ca + Mg)和50、25 mg / kg的钙显着减少跳数。仅在以50/25 mg / kg的CalMag剂量和以25 / 12.5 mg / kg的Ca + Mg剂量施用后,积分排名才降低。除了接受6.25 mg / kg Mg的一组药物外,所有药物治疗组均阻止了吗啡耐受性的发展。数据表明钙和镁在50/25和25 / 12.5 mg / kg的组合会阻止耐受性和依赖性的发展。看来,CalMag胶囊的其他成分对预防耐受性和戒断症状没有重要作用。与急性效应相比,长期服用Cal-Mag可以降低有效剂量。与急性治疗不同,仅长期服用钙可有效降低吗啡耐受性和依赖性,镁对戒断症状无显着影响,提示某些药理学适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号